← Back to Patent Explorer
US4444789A Expired / Lapsed US ⏱️ 0.0 years remaining

Use of 8-anilino-1-naphthalenesulfonate as a vaginal contraceptive

Assignee: University of Georgia Research Foundation Inc
•
Filing: 1982-07-14
•
Granted: 1984-04-24
•
Expires: 2002-07-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The use of 8-anilino-1-naphthalenesulfonate as a vaginal contraceptive is disclosed. The invention may be implemented by incorporating the drug in a known method such as jelly, foam, or suppository introduction means prior to intercourse.

Inventors

  • 👤 Milton J. Cormier

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 13:29
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/13; A61K31/135; A61K31/16; A61K31/18; A61K31/185; A61K31/21; A61K31/215; A61K31/235; A61K31/33; A61K31/395; A61K31/435; A61K31/44; A61K31/445; A61K31/55; A61K9/00; A61K9/0012; A61K9/0034; Y; Y10; Y10S; Y10S424/00; Y10S424/14

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 24 words
A method for preventing conception in a female which comprises: introducing an effective amount of the drug 8-anilino-1-naphthalenesulfonate into the vagina of the female.
Claim 2
Independent Claim 24 words
A method for preventing conception in a female which comprises: introducing an effective amount of the drug 8-anilino-1-naphthalenesulfonate into the vagina of the female.
Claim 3
Dependent Claim 45 words
The method as described in claim 1, wherein the introduction of said drug comprises the steps of : introducing said drug into the vagina of the female prior to sexual intercourse; and allowing said drug to remain in the vagina during and after sexual intercourse.
Claim 4
Dependent Claim 39 words
The method as described in claim 2, wherein the step of introducing said drug comprises introducing a mixture of said drug and a foam carrier into the vagina of the female prior to sexual intercourse by foam injection means.
Claim 5
Dependent Claim 35 words
The method as described in claim 2, wherein the step of introducing said drug comprises introducing a mixture of said drug and jelly carrier into the female prior to sexual intercourse by jelly insertion means.
Claim 6
Dependent Claim 21 words
The method as described in claim 2, wherein said drug is introduced into the vagina of the female by suppository means.
Claim 7
Dependent Claim 23 words
The method as described by claim 3, wherein the amount of the drug introduced into the vagina is about 10 milligrams or greater.
Claim 8
Dependent Claim 23 words
The method as described in claim 4, wherein the amount of the drug introduced into the vagina is about 10 milligrams or greater.
Claim 9
Dependent Claim 23 words
The method as described in claim 5, wherein the amount of the drug introduced into the vagina is about 10 milligrams or greater.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-04-24 1987-10-24 1988-04-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-04-24 1991-10-24 1992-04-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-04-24 1995-10-24 1996-04-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag